JACK O. GREENBERG, M.D., CHAIRMAN; HARRIS HOUSER, M.D.; GEORGE SHEPHERD, M.D.; HENRY HARRIS, M.D.; ANGELO ALVES, M.D.; IMMANUEL MIER, M.D.; GERALD MORLEY, M.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: At the Second Annual Meeting of the Society For Computerized Tomography and Neuro-Imaging held at Hilton Head, North Carolina, 29 October 1978, the subject of contrast enhancement in computed tomography (CT) scanning was discussed. The generally agreed upon indications for the use of intravenous contrast to help delineate lesions of the brain are as follows:
1. Previously treated brain tumors.
2. Abnormal isotope scans, cerebral arteriograms, or other positive neurodiagnostic tests.
3. Possible posterior fossa lesions, especially cerebellar pontine angle tumor.
4. Metastatic disease.
5. Arteriovenous malformations or aneurysms.
6. Patients with focal central nervous system signs.
GREENBERG JO, HOUSER H, SHEPHERD G, HARRIS H, ALVES A, MIER I, et al. Computed Tomography and Contrast Enhancement. Ann Intern Med. ;90:858–859. doi: 10.7326/0003-4819-90-5-858_3
Download citation file:
Published: Ann Intern Med. 1979;90(5):858-859.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use